Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Astellas Targets ALS In Expansion Of Cytokinetics Alliance

Jul 28 2016

• By Ian Haydock

business

Related Content

Cytokinetics plunges as tirasemtiv fails to BENEFIT-ALS

Apr 26 2014

Big US Step For Mitsubishi Tanabe As Edaravone Filed For ALS

Jun 20 2016

Astellas Jump-Starts Ophthalmology Ambitions With Ocata Buy

Nov 10 2015

Cytokinetics gets up to $675m in expanded Astellas deal

Dec 24 2014

Related Companies

Astellas Pharma, Inc.

Cytokinetics, Inc.

Ocata Therapeutics, Inc.

Mitsubishi Tanabe Pharma Corporation

AB Science S.A.

Additional Topics

Research & Development BioPharmaceutical Neurology

More from R&D

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window